Glucose-dependent insulinotropic peptide: Differential effects on hepatic artery vs. portal vein endothelial cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 286, Issue 5 49-5, 2004, Pages

  Ding, Ke Hong ^a   Zhong, Qing ^a   Xu, Jianrui ^a   Isales, Carlos M ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Canine; Endothelin; Nitric oxide; Receptor

Indexed keywords

ENDOTHELIN 1; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; INSULIN; NITRIC OXIDE; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOG; ENDOTHELIUM CELL; HEPATIC ARTERY; NONHUMAN; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLANCHNIC BLOOD FLOW;

NASA DISCIPLINE MUSCULOSKELETAL; NON-NASA CENTER;

ANALYSIS OF VARIANCE; ANIMALS; CALCIUM SIGNALING; CELLS, CULTURED; DOGS; ENDOTHELIAL CELLS; ENDOTHELIN-1; GASTRIC INHIBITORY POLYPEPTIDE; HEPATIC ARTERY; HUMANS; LIVER; NITRIC OXIDE; PORTAL VEIN; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASODILATION;

EID: 1942454241     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00507.2003     Document Type: Article

References (29)

1. Alemany CA, Oh W, and Stonestreet BS. Effects of nitric oxide synthesis inhibition on mesenteric perfusion in young pigs. Am J Physiol Gastrointest Liver Physiol 272: G612-G616, 1997.
2. Barrett PQ and Isales CM. The role of cyclic nucleotides in atrial natriuretic peptide-mediated inhibition of aldosterone secretion. Endocrinology 122: 799-808, 1988.
3. Bollag RJ, Zhong Q, Phillips P, Min L, Zhong L, Cameron R, Mulloy AL, Rasmussen H, Qin F, Ding KH, and Isales CM. Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 141: 1228-1235, 2000.
4. Brubaker PL and Drucker DJ. Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Receptors Channels 8: 179-188, 2002.
5. Ding KH, Zhong Q, and Isales CM. Glucose-dependent insulinotropic peptide stimulates thymidine incorporation in endothelial cells: role of endothelin-1. Am J Physiol Endocrinol Metab 285: E390-E396, 2003.
6. Ehses JA, Lee SS, Pederson RA, and McIntosh CH. A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: Evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion. J Biol Chem 276: 23667-23673, 2001.
7. Fara JW and Salazar AM. Gastric inhibitory polypeptide increases mesenteric blood flow. Proc Soc Exp Biol Med 158: 446-448, 1978.
8. Fehmann HC, Goke R, and Goke B. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev 16: 390-410, 1995.
9. Fieseler P, Bridenbaugh S, Nustede R, Martell J, Orskov C, Holst JJ, and Nauck MA. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8. Am J Physiol Endocrinol Metab 268: E949-E955, 1995.
10. Gama R, Norris F, Wright J, Morgan L, Hampton S, Watkins S, and Marks V. The entero-insular axis in polycystic ovarian syndrome. Ann Clin Biochem 33: 190-195, 1996.
11. Gasalla-Herraiz J, Rhee S, and Isales CM. Calcium-sensitive probes for the measurement of intracellular calcium: effects of buffer system and magnesium concentration. Biochem Biophys Res Commun 214: 373-388, 1995.
12. Herrmann C, Goke R, Richter G, Fehmann HC, Arnold R, and Goke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56: 117-126, 1995.
13. Isales CM, Sumpio B, Bollag RJ, Zhong Q, Ding KH, Du W, Rodriguez-Commes J, Lopez R, Rosales OR, Gasalla-Herraiz J, McCarthy R, and Barrett PQ. Functional parathyroid hormone receptors are present in an umbilical vein endothelial cell line. Am J Physiol Endocrinol Metab 279: E654-E662, 2000.
14. Jia X, Brown JC, Ma P, Pederson RA, and McIntosh CH. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion. Am J Physiol Endocrinol Metab 268: E645-E651, 1995.
15. Kogire M, Inoue K, Sumi S, Doi R, Takaori K, Yun M, Fuji N, Yajima H, and Tobe T. Effects of synthetic human gastric inhibitory polypeptide on splanchnic circulation in dogs. Gastroenterology 95: 1636-1640, 1988.
16. Kogire M, Inoue K, Sumi S, Doi R, Yun M, Kaji H, and Tobe T. Effects of gastric inhibitory polypeptide and glucagon on portal venous and hepatic arterial flow in conscious dogs. Dig Dis Sci 37: 1666-1670, 1992.
17. Kruszynska YT, Ghatei MA, Bloom SR, and McIntyre N. Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis. Hepatology 21: 933-941, 1995.
18. Lacroix A, Bolte E, Tremblay J, Dupre J, Poitras P, Fournier H, Garon J, Garrel D, Bayard F, Taillefer R, Flanagan RJ, and Hamet P. Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing's syndrome. N Engl J Med 327: 974-980, 1992.
19. Ludwig D, Schadel S, Bruning A, Schiefer B, and Stange EF. 48-Hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study. Dig Dis Sci 45: 1019-1027, 2000.
20. Luscher TF and Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102: 2434-2440, 2000.
21. McIntosh CH, Wheeler MB, Gelling RW, Brown JC, and Pederson RA. GIP receptors and signal-transduction mechanisms. Acta Physiol Scand 157: 361-365, 1996.
22. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
23. Schirra J, Katschinski M, Weidmann C, Schafer T, Wank U, Arnold R, and Goke B. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97: 92-103, 1996.
24. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, and Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365: 170-175, 1993.
25. Tamatani S, Ozawa T, Minakawa T, Takeuchi S, Koike T, and Tanaka R. Histological interaction of cultured endothelial cells and endovascular embolic materials coated with extracellular matrix. J Neurosurg 86: 109-112, 1997.
26. Usdin TB, Mezey E, Button DC, Brownstein MJ, and Bonner TI. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133: 2861-2870, 1993.
27. Yip RG, Boylan MO, Kieffer TJ, and Wolfe MM. Functional GIP receptors are present on adipocytes. Endocrinology 139: 4004-4007, 1998.
28. Yip RG and Wolfe MM. GIP biology and fat metabolism. Life Sci 66: 91-103, 2000.
29. Zhong Q, Bollag RJ, Dransfield DT, Gasalla-Herraiz J, Ding K, Min L, and Isales CM. Glucose-dependent insulinotropic peptide signaling pathways in endothelial cells. Peptides 21: 1427-1432, 2000.